Natco Pharma names Imtiyaz Basade as Senior Vice President - RAD, Pharma Division, Kothur Unit
Telangana: Natco Pharma has announced that Imtiyaz Basade has been appointed as Senior Vice President - RAD, Pharma Division, Kothur Unit w.e.f. 4th November, 2024.
Imtiyaz Basade has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends. He was involved in planning and implementation of activities related to mergers and demergers, product acquisitions and divestments. He was also involved in policy framing of the new regulations with aid of industry associations, secretaries of respective ministries and Indian FDA. His managerial competencies are planning, communication and implementation skills, foresight and strategic thinking, system orientation and leadership skills. He has attended international meetings with various agencies like, EDQM, MoH of South Africa, Morocco, Zimbabwe, Kenya, Thailand, Malaysia, WHO Geneva.
Prior to joining with NATCO Pharma Limited Imtiyaz Basade worked with Mylan Laboratories Limited, Orchid Chemicals & Pharmaceuticals Ltd., Wockhardt Limited, Ranbaxy Laboratories Ltd., Dr Reddy's Laboratories Ltd., Lupin Laboratories Ltd., Fulford (India) Ltd., and Pfizer Ltd. He did Master’s in Pharmacy from University Department of Chemical Technology, Bombay University.
Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with modern research laboratories, capabilities in New Drug Development, etc.
Read also: NATCO Pharma Canada arm invests over Rs 67 crore in biotech company eGenesis
Next Story
